丰原药业控股股东及其一致行动人拟向贵和达毅转让5.1%公司股份

Core Viewpoint - Fengyuan Pharmaceutical (000153) announced the transfer of 23.6986 million shares, representing 5.1% of the total share capital, from its controlling shareholder Anhui Fengyuan Group Co., Ltd. to Hainan Guihe Dayi Investment Partnership (Limited Partnership) at a price of 6.72 yuan per share, totaling 159 million yuan, indicating recognition of the company's future development prospects and investment value by Guihe Dayi [1] Group 1 - The controlling shareholder and its concerted party plan to transfer shares through an agreement [1] - The total number of shares being transferred is 23.6986 million, which constitutes 5.1% of the company's total share capital [1] - The agreed transfer price is 6.72 yuan per share, leading to a total transaction value of 159 million yuan [1]